Golden
AVROBIO

AVROBIO

Developing gene therapies to potentially cure rare diseases.

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...

Timeline

People

Name
Role
LinkedIn







Further reading

Title
Author
Link
Type
Date

Avrobio stock plunges after reporting clinical data for its AVR-RD-01 gene therapy to treat rare genetic Fabry disease

Uttara Choudhury

Web



UHN Spin-out AVROBIO, Inc. Announces $25 Million Series A Financing to Advance Novel, Clinical-Stage Gene Therapies for Rare Diseases & Cancer | TDC

Technology Development & Commercialization at UHN

Web



Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services